Inhibition of brain 5α-reductase in pregnant rats: Effects on enzymatic and behavioral activity

Brain Research

Volumn 739, Issue 1-2, 1996, Pages 356-360

  Lephart, Edwin D ^a   Ladle, David R ^a   Jacobson, Nathan A ^a   Rhees, Reuben W ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

5 reductase; brain; finasteride (Proscar); neurosteroids; open field behavior; pregnancy; prenatal development; rodent

Indexed keywords

FINASTERIDE; PROGESTERONE; STEROID 5ALPHA REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOTHALAMUS; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PREGNANCY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENAL GLANDS; ANALYSIS OF VARIANCE; ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; FEMALE; FINASTERIDE; GESTATIONAL AGE; HYPOTHALAMUS, MIDDLE; MALE; OVARY; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0030580392     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01068-2     Document Type: Article

References (34)

1. [1] Backström, T., Gee, K.W., Lan, N.C., Sorensen, M. and Wahlstrom, G., Steroids in relationship to epilepsy and anesthesia. In D. Chadwick and K. Widdows, Eds., Steroids and Neural Activity, Vol. 153, Ciba Foundation Symposium, John Wiley, West Sussex, England, 1990, pp. 225-239.
2. A /benzodiazepine receptor-chloride ionophore complex, Neurosci. Biobehav. Rev., 14 (1990) 315-322.
3. A receptor, Brain Res., 561 (1991) 157-161.
4. A receptors, J. Neuroendocrinol., 7 (1995) 171-177.
5. [5] Celotti, F., Melcangi, R.C. and Martini, L., The 5α-reductase in the brain: Molecular aspects and relation to brain function, Front. Neuroendocrinol., 13 (1992) 163-215.
6. [6] DeBold, J.F. and Frye, C.A., Progesterone and the neural mechanisms of hamster sexual behavior, Psychoneuroendocrinology, 19 (1994) 1-17.
7. [7] Dindi, D., Maggi, R., Panterai, A.E., Piva, F. and Limonia, P., Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat, Neuroendocrinology, 53 (1991) 460-466.
8. [8] Erskine, M.S., Hippensteil, M. and Kornberg, E., Metabolism of dihydrotesterone to 3α-androstanediol in brain and plasma: effect on behavioral activity in female rats, J. Endocrinol., 134 (1992) 183-195.
9. [9] Finn, D.A., Roberts, A.J. and Crabbe, J.C., Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice, Alcohol. Clin. Exp. Res., 19 (1995) 410-415.
10. [10] Flood, J.F., Morley, J.E. and Roberts, E., Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive, Proc. Natl. Acad. Sci. USA, 92 (1995) 10806-10810.
11. A receptor complex, attenuate pain sensitivity in rats, Brain Res., 634 (1994) 194-203.
12. [12] Frye, C.A., The neurosteroid 3α, 5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy, Brain Res., 696 (1995) 113-120.
13. [13] Frye, C.A., Van Keuren, K.R., Rao, P.N. and Erskine, M.S., Analgesic effects of the neurosteroid 3α-androstanediol, Brain Res., 709 (1996) 1-9.
14. [14] Giusti, L., Stefania Belfiore, M., Martini, L. and Lucacchini, A., 3α-Hydrox-5α-pregnan-20-one modulation of solubilized GABA/benzodiazepine receptor complex, J. Steroid Biochem. Mole. Biol., 45 (1993) 309-314.
15. [15] Hiemke, C., Jussofie, A. and Juptner, M., Evidence that 3α-hydroxy-5α-pregnan-20-one is a physiologically relevant modulator of GABA-ergic neurotransmission, Psychoneuroendocrinology, 16 (1991) 517-523.
16. [16] Korneyev, A., Guidotti, A. and Costa, E., Regional and interspecies differences in brain progesterone metabolism, J. Neurochem., 61 (1993) 2041-2047.
17. [17] Lephart, E.D., Andersson, S. and Simpson, E.R., Expression of neural 5α-reductase messenger ribonucleic acid: comparison to 5α-reductase activity during prenatal development in the rat, Endocrinology, 127 (1990) 1121-1128.
18. [18] Lephart, E.D. and Ojeda, S.R., Hypothalamic aromatase activity in male and female rats during juvenile peripubertal development, Neuroendocrinology, 51 (1990) 385-393.
19. [19] Lephart, E.D., Simpson, E.R. and Trzeciak, W.H., Rat adrenal 5α-reductase mRNA content and enzyme activity are sex hormone dependent, J. Mol. Endocrinol., 6 (1991) 163-170.
20. [20] Lephart, E.D., Brain 5α-reductase: Cellular, enzymatic, and molecular perspective and implications for biological function, Mol. Cell. Neurosci., 4 (1993) 473-484.
21. [21] Lephart, E.D., Pituitary and brain 5α-reductase messenger RNA levels in control, castrated and dihydrotestosterone treated rats, Mol. Cell. Neurosci., 4 (1993) 526-531.
22. [22] Lowry, O.H., Rosebrough, N.J., Fair, A.L. and Randall, R.J., Protein determination with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
23. A receptor sensitivity in maternal brain: An antecedent of post-partum 'blues'?, Brain Res., 482 (1989) 397-401.
24. A receptor. Mechanism of action and physiological significance, Prog. Neurobiol., 38 (1992) 379-395.
25. [25] Martini, L., The 5α-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications, Endocrine Rev., 3 (1982) 1-25.
26. [26] McCarthy, M.M., Caba, M., Komisurak, B.R. and Beyer, C., Modulation by estrogen and progesterone on the effect of muscimol on nociception in the spinal cord, Pharmacol. Biochem. Behav., 37 (1990) 123-128.
27. [27] Meyerson, B.J., Relationship between the anesthetic and gestagenic action and estrous-inducing activity of different progestins, Endocrinology, 81 (1967) 369-374.
28. [28] Morishige, W.K., Pepe, G.J. and Rothchild, I., Serum luteinizing hormone, prolactin and progesterone levels during pregnancy in the rat, Endocrinology, 92 (1973) 1527-1530.
29. [29] Norberg, L., Wahlstrom, G. and Backström, T., The anesthetic potency of 5α-hydroxy-5α-pregnan-20-one and 3α-hydroxy-5β-pregnan-20-one determined with an intravenous EEG-threshold method in male rats, Pharmacol. Toxicol., 61 (1987) 42-47.
30. [30] Paul, S.M. and Purdy, R.H., Neuroactive steroids, FASEB J., 6 (1992) 2310-2322.
31. [31] Petraglia, F., Baraldi, M., Giarre, G., Facchinetti, F., Santi, M., Volpe, A. and Genazzani, A.R., Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats, J. Endocrinol., 105 (1985) 239-245.
32. [32] Stoner, E., The clinical development of a 5α-reductase inhibitor, finasteride, J. Steroid Biochem., 37 (1990) 375-378.
33. [33] Wardlaw, S.L. and Frantz, A.G., Brain β-endorphin during pregnancy, parturition, and the postpartum period, Endocrinology, 113 (1983) 1664-1668.
34. [34] Weisz, J. and Ward, I.L., Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring, Endocrinology, 106 (1980) 306-316.